Economic impact of antimicrobial resistance

被引：150

作者：

McGowan, JE ^{[1
]}

机构：

[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA

来源：

EMERGING INFECTIOUS DISEASES | 2001年 / 7卷 / 02期

关键词：

D O I：

10.3201/eid0702.010228

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

One reason antimicrobial-drug resistance is of concern is its economic impact on physicians, patients, health-care administrators, pharmaceutical producers, and the public. Measurement of cost and economic impact of programs to minimize antimicrobial-drug resistance is imprecise and incomplete. Studies to describe and evaluate the problem will have to employ new methods and be of large scale to produce information that is broadly applicable.

引用

收藏

页码：286 / 292

页数：7

相关论文

共 59 条

[1] Nosocomial methicillin-resistant and methicillin-susceptible, Staphylococcus aureus primary bacteremia:: At what costs [J].

Abramson, MA ;

Sexton, DJ .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (06) :408-411

[2]

[Anonymous], 2000, MED LETT DRUGS THER, V42, P15

[3] The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance [J].

Austin, DJ ;

Kristinsson, KG ;

Anderson, RM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1152-1156

[4] A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia [J].

Bhavnani, SM ;

Drake, JA ;

Forrest, A ;

Deinhart, JA ;

Jones, RN ;

Biedenbach, DJ ;

Ballow, CH .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (03) :145-158

[5] Evidence of delays in transferring patients with methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus to long-term-care facilities [J].

Bryce, EA ;

Tiffin, SM ;

Isaac-Renton, JL ;

Wright, CJ .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (04) :270-271

[6] Antibiotic resistance - Squeezing the balloon? [J].

Burke, JP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (14) :1270-1271

[7] Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa [J].

Carmeli, Y ;

Troillet, N ;

Karchmer, AW ;

Samore, MH .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1127-1132

[8]

Chrischilles E A, 1999, Clin Perform Qual Health Care, V7, P107

[9] An economic perspective on policy to reduce antimicrobial resistance [J].

Coast, J ;

Smith, RD ;

Millar, MR .

SOCIAL SCIENCE & MEDICINE, 1998, 46 (01) :29-38

[10]

Coast J, 1996, HEALTH ECON, V5, P217, DOI 10.1002/(SICI)1099-1050(199605)5:3<217::AID-HEC200>3.0.CO

← 1 2 3 4 5 6 →